Finance
Pharmos Corporation reports 2006 third quarter net loss of $4.2 million
Published in Healthcare Mergers, Acquisitions and Ventures Week, December 9th, 2006
Cash and short-term investments totaled $35.3 million at September 30, 2006.
The acquisition of Vela Pharmaceuticals Inc. (Vela) was a major focus during the quarter. The transaction expands Pharmos' pipeline with later-stage clinical drug candidates including dextofisopam, a promising and innovative new drug that has demonstrated positive Phase IIa data for the treatment of diarrhea-predominant and alternating-type...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- Accreditation
Skirball Hospice awarded accreditation from the National Institute of Jewish Hospice - Acute Myeloid Leukemia
EpiCept announces successful validation of Marketing Authorization application for Ceplene in AML - Aging Research
Reduced body temperature extends lifespan in mouse study from the Scripps Research Institute - Allergy & Immunology
Ranbaxy receives tentative U.S. approval to manufacture and market cetirizine hydrochloride syrup - Allergy & Immunology
U.S. Food and Drug Administration calls for halt to manufacture of knock-off nebulizer medications - Alzheimer Disease
New alzheimer disease data have been reported by scientists at Stanford University, Department of Psychiatry and Behavioral Sciences - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
